INDV-6000-400: A Randomised, Double-Blind Study Comparing 2 Maintenance Dosing Regimens of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in Treatment-Seeking Adult Participants with Opioid Use Disorder and High-risk Opioid Use
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology
Awarded By
INDIVIOR
Start Date
March 2, 2022
End Date
February 29, 2024
Administered By
Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology
Awarded By
INDIVIOR
Start Date
March 2, 2022
End Date
February 29, 2024